These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16263293)

  • 21. Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors.
    Giorgi I; Leonardi M; Pietra D; Biagi G; Borghini A; Massarelli I; Ciampi O; Bianucci AM
    Bioorg Med Chem; 2009 Mar; 17(5):1817-30. PubMed ID: 19230680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radial distribution function descriptors: an alternative for predicting A2 A adenosine receptors agonists.
    González MP; Terán C; Teijeira M; Helguera AM
    Eur J Med Chem; 2006 Jan; 41(1):56-62. PubMed ID: 16253394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A segmented principal component analysis-regression approach to quantitative structure-activity relationship modeling.
    Hemmateenejad B; Elyasi M
    Anal Chim Acta; 2009 Jul; 646(1-2):30-8. PubMed ID: 19523553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of a bivalent micro opiate and adenosine A1 receptor antagonist.
    Mathew SC; Ghosh N; By Y; Berthault A; Virolleaud MA; Carrega L; Chouraqui G; Commeiras L; Condo J; Attolini M; Gaudel-Siri A; Ruf J; Parrain JL; Rodriguez J; Guieu R
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6736-9. PubMed ID: 19836950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QSAR study on thiazole and thiadiazole analogues as antagonists for the adenosine A1 and A3 receptors.
    Borghini A; Pietra D; Domenichelli P; Bianucci AM
    Bioorg Med Chem; 2005 Sep; 13(18):5330-7. PubMed ID: 15990318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung.
    Heller AR; Rothermel J; Weigand MA; Plaschke K; Schmeck J; Wendel M; Bardenheuer HJ; Koch T
    Eur J Anaesthesiol; 2007 Mar; 24(3):258-66. PubMed ID: 17094869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
    Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
    Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine receptor modelling. A1/A2a selectivity.
    Tuccinardi T; Ortore G; Manera C; Saccomanni G; Martinelli A
    Eur J Med Chem; 2006 Mar; 41(3):321-9. PubMed ID: 16427161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSAR of adenosine A3 receptor antagonist 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives using chemometric tools.
    Bhattacharya P; Roy K
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3737-43. PubMed ID: 15993066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporating molecular shape into the alignment-free Grid-Independent Descriptors.
    Fontaine F; Pastor M; Sanz F
    J Med Chem; 2004 May; 47(11):2805-15. PubMed ID: 15139758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
    Cappellacci L; Franchetti P; Vita P; Petrelli R; Lavecchia A; Costa B; Spinetti F; Martini C; Klotz KN; Grifantini M
    Bioorg Med Chem; 2008 Jan; 16(1):336-53. PubMed ID: 17933541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor.
    Xia B; Ma W; Zheng B; Zhang X; Fan B
    Eur J Med Chem; 2008 Jul; 43(7):1489-98. PubMed ID: 17964693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists.
    Elzein E; Kalla R; Li X; Perry T; Marquart T; Micklatcher M; Li Y; Wu Y; Zeng D; Zablocki J
    Bioorg Med Chem Lett; 2007 Jan; 17(1):161-6. PubMed ID: 17045477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
    Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M
    J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
    J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative structure-activity relationship modeling of juvenile hormone mimetic compounds for Culex pipiens larvae, with a discussion of descriptor-thinning methods.
    Basak SC; Natarajan R; Mills D; Hawkins DM; Kraker JJ
    J Chem Inf Model; 2006; 46(1):65-77. PubMed ID: 16426041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR study of imidazoline antihypertensive drugs.
    Nikolic K; Filipic S; Agbaba D
    Bioorg Med Chem; 2008 Aug; 16(15):7134-40. PubMed ID: 18621536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A highly conserved tryptophan residue in the fourth transmembrane domain of the A adenosine receptor is essential for ligand binding but not receptor homodimerization.
    Suzuki T; Namba K; Yamagishi R; Kaneko H; Haga T; Nakata H
    J Neurochem; 2009 Aug; 110(4):1352-62. PubMed ID: 19558453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidimensional drug design: simultaneous analysis of binding and relative efficacy profiles of N(6)-substituted-4'-thioadenosines A3 adenosine receptor agonists.
    Cruz-Monteagudo M; Cordeiro MN; Teijeira M; González MP; Borges F
    Chem Biol Drug Des; 2010 Jun; 75(6):607-18. PubMed ID: 20408851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors.
    Manetti F; Schenone S; Bondavalli F; Brullo C; Bruno O; Ranise A; Mosti L; Menozzi G; Fossa P; Trincavelli ML; Martini C; Martinelli A; Tintori C; Botta M
    J Med Chem; 2005 Nov; 48(23):7172-85. PubMed ID: 16279775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.